CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 180 filers reported holding CHEMOCENTRYX INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,122,000 | -70.7% | 41,068 | -88.5% | 0.00% | -71.4% |
| Q2 2022 | $7,250,000 | -8.6% | 357,020 | -13.3% | 0.01% | +16.7% |
| Q1 2022 | $7,934,000 | -21.6% | 411,633 | +48.2% | 0.01% | -25.0% |
| Q4 2021 | $10,116,000 | +66.5% | 277,838 | -21.8% | 0.01% | +60.0% |
| Q3 2021 | $6,074,000 | +29.5% | 355,190 | +1.4% | 0.01% | +25.0% |
| Q2 2021 | $4,690,000 | -65.8% | 350,286 | +30.9% | 0.00% | -71.4% |
| Q1 2021 | $13,712,000 | -3.0% | 267,607 | +17.2% | 0.01% | -12.5% |
| Q4 2020 | $14,143,000 | +215.2% | 228,403 | +179.0% | 0.02% | +166.7% |
| Q3 2020 | $4,487,000 | +22.5% | 81,879 | +28.7% | 0.01% | +20.0% |
| Q2 2020 | $3,662,000 | +59.9% | 63,637 | +11.6% | 0.01% | +25.0% |
| Q1 2020 | $2,290,000 | +86.6% | 57,003 | +83.8% | 0.00% | +100.0% |
| Q4 2019 | $1,227,000 | +815.7% | 31,014 | +56.9% | 0.00% | – |
| Q3 2019 | $134,000 | -2.9% | 19,767 | +33.3% | 0.00% | – |
| Q2 2019 | $138,000 | -28.5% | 14,824 | +6.8% | 0.00% | – |
| Q1 2019 | $193,000 | +45.1% | 13,874 | +14.0% | 0.00% | – |
| Q4 2018 | $133,000 | – | 12,174 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |